Cell Wall Thickening Is Not a Universal Accompaniment of the Daptomycin Nonsusceptibility Phenotype in Staphylococcus aureus : Evidence for Multiple Resistance Mechanisms
- 1 August 2010
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (8) , 3079-3085
- https://doi.org/10.1128/aac.00122-10
Abstract
The mechanism(s) of daptomycin (DAP) resistance (DAP r ) is incompletely defined. Thickened cell walls (CWs) acting as either a mechanical barrier or an affinity trap for DAP have been purported to be a major contributor to the DAP r phenotype. To this end, we studied an isogenic set of methicillin-resistant Staphylococcus aureus (MRSA) isolates (pulsotype USA 300) from the bloodstream of a DAP-treated patient with endocarditis in which serial strains exhibited increasing DAP r . Of interest, the DAP r isolate differed from its parental strain in several parameters, including acquisition of a point mutation within the putative synthase domain of the mprF gene in association with enhanced mprF expression, increased synthesis of lysyl-phosphotidylglycerol, an enhanced positive envelope charge, and reduced DAP surface binding. Transmission electron microscopy (TEM) revealed no significant increases in CW thickness in the two DAP r isolates (MRSA 11/21 and REF2145) compared with that in the DAP-susceptible (DAP s ) parental strain, MRSA 11/11. The rates of Triton X-100-induced autolysis were also identical for the strain set. Furthermore, among six additional clinically isolated DAP s /DAP r S. aureus strain pairs, only three DAP r isolates exhibited CWs significantly thicker than those of the respective DAP s parent. These data confirm that CW thickening is neither universal to DAP r S. aureus nor sufficient to yield the DAP r phenotype among S. aureus strains.Keywords
This publication has 41 references indexed in Scilit:
- Enhanced Expression ofdltABCDIs Associated with the Development of Daptomycin Nonsusceptibility in a Clinical Endocarditis Isolate ofStaphylococcus aureusThe Journal of Infectious Diseases, 2009
- Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2009
- Serial Daptomycin Selection Generates Daptomycin-NonsusceptibleStaphylococcus aureusStrains with a Heterogeneous Vancomycin-Intermediate PhenotypeAntimicrobial Agents and Chemotherapy, 2008
- Failures in Clinical Treatment of Staphylococcus aureus Infection with Daptomycin Are Associated with Alterations in Surface Charge, Membrane Phospholipid Asymmetry, and Drug BindingAntimicrobial Agents and Chemotherapy, 2008
- Characterization of a Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus Strain in a Patient with EndocarditisAntimicrobial Agents and Chemotherapy, 2007
- Interaction of the GraRS Two-Component System with the VraFG ABC Transporter To Support Vancomycin-Intermediate Resistance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2007
- Daptomycin Nonsusceptibility in Staphylococcus aureus with Reduced Vancomycin Susceptibility Is Independent of Alterations in MprFAntimicrobial Agents and Chemotherapy, 2007
- Comparative Bactericidal Activities of Daptomycin and Vancomycin against Glycopeptide-Intermediate Staphylococcus aureus (GISA) and Heterogeneous GISA IsolatesAntimicrobial Agents and Chemotherapy, 2006
- A Synthetic Congener Modeled on a Microbicidal Domain of Thrombin- Induced Platelet Microbicidal Protein 1 Recapitulates Staphylocidal Mechanisms of the Native MoleculeAntimicrobial Agents and Chemotherapy, 2006
- Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2006